Literature DB >> 24062344

Decreased iron levels in the temporal cortex in postmortem human brains with Parkinson disease.

Osamu Kano1, Ken Ikeda, Yasuo Iwasaki, Hong Jiang.   

Abstract

Yu et al.(1) reported that iron levels in the temporal cortex were reduced in patients with Parkinson disease (PD) compared with age-matched controls. They also determined that patients with Alzheimer disease (AD) had no change in iron levels in the temporal cortex. We would like to know whether Yu et al.(1) included any patients with memory disturbance in this study.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24062344     DOI: 10.1212/01.wnl.0000435455.95141.16

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  1 in total

1.  Transferrin protects against Parkinsonian neurotoxicity and is deficient in Parkinson's substantia nigra.

Authors:  Scott Ayton; Peng Lei; Catriona Mclean; Ashley I Bush; David I Finkelstein
Journal:  Signal Transduct Target Ther       Date:  2016-09-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.